Functional Consequences of Cocaine Re-exposure after Discontinuation of Cocaine Availability.

Neuropharmacology (Impact Factor: 5.11). 06/2014; 85. DOI: 10.1016/j.neuropharm.2014.06.003
Source: PubMed


Cocaine users exhibit a wide range of behavioral impairments accompanied by brain structural, neurochemical and functional abnormalities. Metabolic mapping studies in cocaine users and animal models have shown extensive functional alterations throughout the striatum, limbic system, and cortex. Few studies, however, have evaluated the persistence of these effects following cessation of cocaine availability. The purpose of this study, therefore, was to assess the functional effects of re-exposure to cocaine in nonhuman primates after the discontinuation of cocaine self-administration for 30 or 90 days, using the quantitative autoradiographic 2-[(14)C]deoxyglucose (2DG) method. Rhesus monkeys self-administered cocaine (fixed interval 3-min schedule, 30 infusions per session, 0.3 mg/kg/infusion) for 100 sessions followed by 30 (n=4) or 90 days (n=3) during which experimental sessions were not conducted. Food-reinforced control animals (n=5) underwent identical schedules of reinforcement. Animals were then re-exposed to cocaine or food for one final session and the 2DG method applied immediately after session completion. Compared to controls, re-exposure to cocaine after 30 or 90 day drug-free periods resulted in lower rates of glucose utilization in ventral and dorsal striatum, prefrontal and temporal cortex, limbic system, thalamus, and midbrain. These data demonstrate that vulnerability to the effects of cocaine persists for as long as 90 days after cessation of drug use. While there was some evidence for recovery (fewer brain areas were affected by cocaine re-exposure at 90 days as compared to 30 days), this was not uniform across regions, thus suggesting that recovery occurs at different rates in different brain systems.

Download full-text


Available from: Thomas J R Beveridge, Aug 20, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Here we reported a novel label-free colorimetric biosensing strategy based on graphene−hemin hybrid nanosheets (GHs) for DNA and small molecule assays. GHs were synthesized by a simple wet-chemical method and possessed excellent properties of both graphene and hemin. When being mixed with ssDNA, GHs exhibited enhanced catalytic activity in the presence of ABTS and H2O2. In contrast, the GHs mixed with dsDNA had lower catalytic activity than that mixed with ssDNA. On the basis of this property of GHs, a novel universal label-free colorimetric method was proposed. This simple strategy owns the merits over conventional assays in its label-free design, extreme operation simplicity and low cost. DNA and cocaine were studied as model cases and the results revealed the developed method had a potential of becoming a universal platform for detection of a wide range of analytes.
    RSC Advances 10/2014; 4(109). DOI:10.1039/C4RA08789E · 3.84 Impact Factor